Skip to main content
Clinical Trials/NCT02653352
NCT02653352
Completed
Not Applicable

School Randomised Trial on Prevention of Excessive Weight Gain by Discouraging Students From Drinking Sodas

Rio de Janeiro State University0 sites1,140 target enrollmentMarch 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight
Sponsor
Rio de Janeiro State University
Enrollment
1140
Primary Endpoint
Change in body mass index (kg/m²)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study was to encourage students to reduce soft drinks intake, substituting it by water, in order to prevent and control overweight prevalence.

Detailed Description

During seven months of one school year, a healthy lifestyle education programme was implemented using simple messages encouraging water consumption instead of sugar sweetened carbonated beverages. The messages were previously tested for understanding in two small groups of children of the same age and socio-economic background as the study participants. Also, beliefs and behaviors of children in these focus groups were recorded in order to orient activities and the production of printed materials to be given to participants. Education was delivered via classroom activities; banners were hung promoting water consumption, and water bottles with the logo of the campaign were given to children and schoolteachers.

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
December 2005
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rio de Janeiro State University
Responsible Party
Principal Investigator
Principal Investigator

Rosely Sichieri

Professor

Rio de Janeiro State University

Eligibility Criteria

Inclusion Criteria

  • 4th grade morning classes

Exclusion Criteria

  • Pregnancy
  • Physical disabilities preventing anthropometric measurement

Outcomes

Primary Outcomes

Change in body mass index (kg/m²)

Time Frame: baseline, 8 months

We have calculated changes in body mass index (BMI in follow-up minus BMI on baseline) and compared mean changes between control and intervention groups, in order to address differences in BMI gain among groups.

Secondary Outcomes

  • Change in blood glucose(baseline, 8 months)
  • Change in overweight prevalence as assessed by percentage of overweight participants(baseline, 8 months)
  • Change in blood cholesterol(baseline, 8 months)
  • Change in obesity prevalence as assessed by percentage of obese participants(baseline, 8 months)

Similar Trials